Azd1402

1 study on Azd1402 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Azd1402. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Azd1402 studies and clinical research

2026-04-29 PubMed · rct · n=150

AZD1402 (Elarekibep) Shows Low Immunogenicity in Early Human Trials

The low immunogenicity profile of AZD1402 (Elarekibep) is a critical finding, as it significantly reduces the risk of immune-mediated adverse events and potential loss of drug efficacy over time. This data provides st…

Research tools

Free, no account — handy when you're working with Azd1402.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Azd1402 studies and clinical research

AZD1402 (Elarekibep) Shows Low Immunogenicity in Early Human Trials

Research tools